Itralom 400 SR Tablet contains Itraconazole (400 mg), a broad-spectrum antifungal medication belonging to the azole class. It is designed as a sustained-release (SR) formulation to provide a controlled and prolonged therapeutic effect, ensuring consistent efficacy against various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to the disruption of fungal growth and replication.
This medication is particularly effective against systemic and localized fungal infections caused by susceptible fungi, including infections of the skin, nails, mouth, throat, lungs, and other organs. Its broad antifungal spectrum covers dermatophytes, yeasts, and molds, making it a versatile option for treating complex and recurrent fungal conditions.
The sustained-release design of Itralom 400 SR Tablet enhances patient convenience by reducing the frequency of dosing, which promotes better adherence to the prescribed treatment regimen. This feature is particularly beneficial in the management of chronic or long-term fungal infections.